Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Food Sci ; 84(10): 3027-3036, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31529805

RESUMO

This study aimed to investigate the effect of Se (Selenium) treatment on nutritional quality in radish sprouts. The results showed that 15 µM sodium selenite significantly increased phenolics compounds, flavonoids compounds, anthocyanins, and some essential amino acid content, while improving the total antioxidant capacity of radish sprouts. Besides, the Se-enriched radish sprouts significantly alleviated the liver damage caused by carbon tetrachloride (CCl4 ) in mice and improved the antioxidant capacity of the liver in mice, whereas the Se-enriched radish sprouts alleviated the inflammatory reaction and apoptosis caused by CCl4 . These results imply that Se-enriched radish sprouts have a positive impact on mice with CCl4 -induced liver injury, and that in future Se-enriched radish sprouts could be developed into an effective food and health care product for the liver injury prevention. PRACTICAL APPLICATION: Because selenium is an essential trace element in the human body, selenium-enriched sprouts can help eliminate free radicals in the body, relieve aging, and selenium-deficient diseases. They are easy to grow and have low costs. Hence, selenium-enriched sprouts have a great potential of being widely consumed.


Assuntos
Tetracloreto de Carbono/efeitos adversos , Doença Hepática Crônica Induzida por Substâncias e Drogas/dietoterapia , Substâncias Protetoras/metabolismo , Raphanus/metabolismo , Selênio/metabolismo , Animais , Antocianinas/análise , Antocianinas/metabolismo , Antioxidantes/análise , Antioxidantes/metabolismo , Doença Hepática Crônica Induzida por Substâncias e Drogas/etiologia , Doença Hepática Crônica Induzida por Substâncias e Drogas/metabolismo , Doença Hepática Crônica Induzida por Substâncias e Drogas/prevenção & controle , Flavonoides/análise , Flavonoides/metabolismo , Humanos , Fígado/metabolismo , Masculino , Fenóis/análise , Fenóis/metabolismo , Substâncias Protetoras/análise , Raphanus/química , Raphanus/crescimento & desenvolvimento , Ratos , Ratos Wistar , Plântula/química , Plântula/crescimento & desenvolvimento , Plântula/metabolismo , Sementes/química , Sementes/crescimento & desenvolvimento , Sementes/metabolismo , Selênio/análise
2.
J Vet Intern Med ; 23(5): 957-63, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19627473

RESUMO

BACKGROUND: Copper-associated chronic hepatitis (CACH) recently has been recognized in the Labrador Retriever as an inherited disorder with a late onset of clinical signs. No studies have investigated dietary management for the long-term treatment of this disease or for its potential in delaying the onset of clinical signs in subclinical cases. OBJECTIVES: To investigate the effects of a low-copper diet and zinc gluconate on hepatic copper concentrations in Labrador Retrievers with abnormal hepatic copper concentrations. ANIMALS: Twenty-four client-owned Labradors that were related to patients affected with CACH and that had been diagnosed with increased hepatic copper concentrations. METHODS: Hepatic copper concentrations were assessed before and after an average of 8 and 16 months of treatment. During this time, all dogs were fed exclusively a low-copper diet. In addition, dogs were assigned to 1 of 2 groups in a randomized double-blind manner to receive a supplement of zinc gluconate or placebo. RESULTS: Twenty-one dogs completed the study. Hepatic copper concentrations decreased in both groups at recheck 1 (n = 21; group 1, P < .001; group 2, P= .001) and at recheck 2 (n= 16; group 1, P= .03; group 2, P= .04). No difference in hepatic copper concentrations was found between the 2 groups before treatment (P= .65), at recheck 1 or at recheck 2 (P= .52-.79). CONCLUSIONS AND CLINICAL RELEVANCE: Feeding low-copper diets to Labradors is effective in decreasing hepatic copper concentrations. Adjunctive treatment with zinc does not appear to increase the copper-lowering effects of dietary management.


Assuntos
Doença Hepática Crônica Induzida por Substâncias e Drogas/veterinária , Cobre/metabolismo , Doenças do Cão/dietoterapia , Doenças do Cão/metabolismo , Gluconatos/administração & dosagem , Hepatite Animal/induzido quimicamente , Animais , Biópsia/veterinária , Doença Hepática Crônica Induzida por Substâncias e Drogas/dietoterapia , Doença Hepática Crônica Induzida por Substâncias e Drogas/metabolismo , Cobre/administração & dosagem , Cães , Método Duplo-Cego , Feminino , Predisposição Genética para Doença , Gluconatos/farmacocinética , Hepatite Animal/dietoterapia , Histocitoquímica , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA